Long Beach, CANCT07369011Now EnrollingIRB Ready

Sleep Apnea, Obstructive Clinical Trial in Long Beach, CA

Access cutting-edge sleep apnea, obstructive treatment through this clinical trial at a research site in Long Beach. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Long Beach location

Preparing your pre-screening questions…

Expert Care in Long Beach

Access sleep apnea, obstructive specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sleep apnea, obstructive treatment provided free

Apply for This Long Beach Location

Check if you qualify for this sleep apnea, obstructive clinical trial in Long Beach, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Long Beach

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Long Beach site if eligible
  4. 4Begin participation

About This Sleep Apnea, Obstructive Study in Long Beach

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight. YDAO is a master protocol designed to support two independent studies: YSA1 and YSA2. Study YSA1 will include participants who are unable or unwilling to use Positive Airway Pressure (PAP) therapy and study YSA2 will include participants who are on PAP therapy for at least 3 months at time of screening and plan to continue PAP therapy during the study. Participants will be assigned to the Intervention-Specific Appendix (ISA) that reflects their current PAP usage. Participation in the study will last about 76 weeks.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Confirmed history of moderate-to-severe OSA
Have an AHI ≥ 15 on polysomnography (PSG) as part of the study at screening
Have a BMI ≥27 kg/m2 at screening
Have a stable body weight (\<5% body weight change) for 90 days prior to screening
Have a history of at least one self-reported unsuccessful dietary effort to reduce body weight For YSA1 Participants:
Are unable or unwilling to use PAP therapy For YSA2 Participants:
Have been on PAP therapy for at least three consecutive months prior to screening and plan to continue PAP therapy during the study

Exclusion Criteria

Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed \>1 year before screening)
Have a prior or planned endoscopic procedure and/or device-based therapy for obesity (prior device-based therapy acceptable if device removal was more than 6 months prior to screening)
Any previous or planned surgery for sleep apnea or major ear, nose or throat surgery that still may affect breathing at time of screening
Have type 1 diabetes, type 2 diabetes, or any other type of diabetes
Have had within 90 days prior to screening:
acute myocardial infarction
cerebrovascular accident (stroke)
coronary artery revascularization
unstable angina, or
hospitalization due to congestive heart failure
Have a history or diagnosis of New York Heart Association Functional Classification Class IV congestive heart failure
Have taken medications or alternative remedies intended for weight loss within 90 days of screening

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Long Beach?

Yes, this clinical trial (NCT07369011) has an active research site in Long Beach, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sleep Apnea, Obstructive Treatment Options in Long Beach, CA

If you're searching for sleep apnea, obstructive treatment options in Long Beach, CA, this clinical trial (NCT07369011) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Long Beach research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sleep apnea, obstructive specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sleep apnea, obstructive clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in Long Beach, CA

See all lupus clinical trials recruiting in Long Beach — not just this study.

Browse Lupus Trials in Long Beach

Ready to Join in Long Beach?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Long Beach, CA